NewsBenzingaNANO-X IMAGING 表示,董事会已批准一项计划,目标是在全面实施后,将年度化运营费用较 2026 年年度化 GAAP 和非 GAAP 运营费用减少 25%–30%,预计将在 2027 年第一季度末前完成实施 NANO-X IMAGING 表示,董事会已批准一项计划,目标是在全面实施后,将年度化运营费用较 2026 年年度化 GAAP 和非 GAAP 运营费用减少 25%–30%,预计将在 2027 年第一季度末前完成实施 Benzinga 2026.11.09 22:52 (GMT+0) Open on Benzinga Other news Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 Stifel Maintains Buy on Ecolab, Raises Price Target to $356 Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $26 Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients